Literature DB >> 22796291

Modulatory effects of acupuncture on murine depression-like behavior following chronic systemic inflammation.

Sunoh Kwon1, Bombi Lee, Mijung Yeom, Bong-Jun Sur, Myunghwan Kim, Seung-Tae Kim, Hi-Joon Park, Hyejung Lee, Dae-Hyun Hahm.   

Abstract

Depression associated with inflammatory immune responses may be an important medical problem from the perspective of quality of life in old age because chronic inflammation is recognized to have a close connection with the aging process. Activated proinflammatory cytokines induce depression-like behavior by stimulating the expression of indoleamine-2,3-dioxygenase, an enzyme catalyzing the conversion of tryptophan to kynurenine, and by reducing brain synaptic activities of serotonin and dopamine. Experimental inoculation of Bacillus Calmette-Guérin vaccine (BCG) in the mouse gradually and continuously elicits chronic inflammation-associated depression-like behavior. Despite extensive use of acupuncture therapy for treating various psychosomatic disorders in the Oriental medicine, an experimental study showing antidepressant-like activity of acupuncture stimulation has not been performed in the inflammation-associated depression-like animal behavior yet. In the present study, the antidepressant-like activity of acupuncture and its mechanism of action were investigated in BCG-inoculated mice. We confirmed that acupuncture stimulation significantly reduced depression-like behavior and that it lowered the kynurenine/tryptophan ratio and raised the serum kynurenic acid/3-hydroxykynurenine ratio. Acupuncture also relieved the hippocampal dopamine level that was lowered by BCG inoculation. Taken together, these findings may indicate that acupuncture has antidepressant-like effects on murine chronic inflammation-associated depression-like behavior due to its modulatory effects on tryptophan-kynurenine metabolism and dopamine metabolism in the brain.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22796291     DOI: 10.1016/j.brainres.2012.07.009

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Involvement of purinergic P2Y1R in antidepressant-like effects of electroacupuncture treatment on social isolation stress mice.

Authors:  Lingling Yu; Yao Wang; Hong Zhang; Man Li; Guang Chen; Jiahuan Hao; Minjie Xie
Journal:  Purinergic Signal       Date:  2022-01-30       Impact factor: 3.765

2.  Disruption of microglia histone acetylation and protein pathways in mice exhibiting inflammation-associated depression-like symptoms.

Authors:  Sandra L Rodriguez-Zas; Cong Wu; Bruce R Southey; Jason C O'Connor; Scott E Nixon; Robmay Garcia; Cynthia Zavala; Marcus Lawson; Robert H McCusker; Elena V Romanova; Jonathan V Sweedler; Keith W Kelley; Robert Dantzer
Journal:  Psychoneuroendocrinology       Date:  2018-06-30       Impact factor: 4.905

Review 3.  Research advances in treatment of neurological and psychological diseases by acupuncture at the Acupuncture Meridian Science Research Center.

Authors:  Bombi Lee; Seung-Nam Kim; Hi-Joon Park; Hyejung Lee
Journal:  Integr Med Res       Date:  2014-04-01

4.  Electroacupuncture Promotes Remyelination after Cuprizone Treatment by Enhancing Myelin Debris Clearance.

Authors:  Keying Zhu; Jingxian Sun; Zheng Kang; Zaofeng Zou; Gencheng Wu; Jun Wang
Journal:  Front Neurosci       Date:  2017-01-10       Impact factor: 4.677

5.  Tyrosine Kinase Receptors Axl and MerTK Mediate the Beneficial Effect of Electroacupuncture in a Cuprizone-Induced Demyelinating Model.

Authors:  Zaofeng Zou; Jingxian Sun; Zheng Kang; Yumeng Wang; Hui Zhao; Keying Zhu; Jun Wang
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-04       Impact factor: 2.629

6.  Study on Biomarkers Related to the Treatment of Post-Stroke Depression and Alternative Medical Treatment Methods.

Authors:  Menghan Li; Ran Ding; Xinming Yang; Dawei Ran
Journal:  Neuropsychiatr Dis Treat       Date:  2022-08-26       Impact factor: 2.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.